These findings refine our understanding of CVD pathogenesis in autoimmunity by linking immune dysregulation with procoagulant cellular signaling (e.g., via lipid rafts, mTOR, or platelet heparanase pathways) in conditions like APS, SLE, RA, and iTTP. This evidence concerns the gene MTOR and rheumatoid arthritis.